Harvest Health & Recreation Inc. announced two additions to the senior leadership team. Scott Atkison joins Harvest as Co-Executive Chairman in a non-board capacity. Daniel Reine joins as a special advisor to Harvest's board. Both Atkison and Reiner will bring valuable expertise, networks and skills to Harvest as it focuses on new capital markets and fundraising in 2020. The company will make room for Atkison on the board at its next opportunity. In their roles Reiner and Atkison will prioritize capital markets and fundraising. Harvest Executive Chairman Jason Vedadi will focus on real estate, construction efforts and investment, which will be especially important in 2020 as the company works to refine existing facilities and build new ones, and on raising sufficient capital to enable Harvest to deliver on its promises to customers, employees and shareholders alike. Incoming co-executive chairman Scott Atkison is a veteran business operator and investor who has two successful years of experience in the cannabis industry. In 2008, he played an instrumental role in merging his family's lumber manufacturing business with a separate family- owned lumber firm to form Idaho Forest Group, one of the larger privately held lumber companies in North America. Atkison assumed the role of President and CEO of the Idaho Forest Group before he and his family sold their ownership in 2016 and formed a family office primarily focused on investing in real estate and privately held operating companies. Currently, Atkison serves on the Board of Idaho-based Mountain West Bank and has majority ownership in four cannabis retail stores in Washington State. His stores perform among the top dispensary operators in terms of revenue and profitability. Atkison began his career with KPMG. Reiner is a serial entrepreneur and investor. In 2008 he co-founded Stemcentrx, combining scientific talent from leading enterprises and academic labs, a stem cell-centric philosophy and cutting-edge technologies to develop novel cancer therapies and diagnostics. AbbVie Inc. acquired Stemcentrx in a cash and stock deal worth approximately $5.8 billion. As CEO and Chairman of the Board of World Wide Packets,Reiner sold the company to Ciena for approximately $290 million in 2008. As CEO of Optical Devices Inc., Reiner oversaw the purchase of the specialty films division from Hoechst AG, merging the companies into Enhanced Imaging Technologies Inc., which he took public in 1992 and sold to Marquette Electronics for $300 million in 1993.